Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amgen Net Income 2010-2025 | AMGN

Amgen annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Amgen net income for the quarter ending March 31, 2025 was $1.730B, a 1630.97% decline year-over-year.
  • Amgen net income for the twelve months ending March 31, 2025 was $5.933B, a 57.67% increase year-over-year.
  • Amgen annual net income for 2024 was $4.09B, a 39.11% decline from 2023.
  • Amgen annual net income for 2023 was $6.717B, a 2.52% increase from 2022.
  • Amgen annual net income for 2022 was $6.552B, a 11.18% increase from 2021.
  
Amgen Annual Net Income
(Millions of US $)
2024 $4,090
2023 $6,717
2022 $6,552
2021 $5,893
2020 $7,264
2019 $7,842
2018 $8,394
2017 $1,979
2016 $7,722
2015 $6,939
2014 $5,158
2013 $5,081
2012 $4,345
2011 $3,683
2010 $4,627
2009 $4,605
Amgen Quarterly Net Income
(Millions of US $)
2025-03-31 $1,730
2024-12-31 $627
2024-09-30 $2,830
2024-06-30 $746
2024-03-31 $-113
2023-12-31 $767
2023-09-30 $1,730
2023-06-30 $1,379
2023-03-31 $2,841
2022-12-31 $1,616
2022-09-30 $2,143
2022-06-30 $1,317
2022-03-31 $1,476
2021-12-31 $1,899
2021-09-30 $1,884
2021-06-30 $464
2021-03-31 $1,646
2020-12-31 $1,615
2020-09-30 $2,021
2020-06-30 $1,803
2020-03-31 $1,825
2019-12-31 $1,703
2019-09-30 $1,968
2019-06-30 $2,179
2019-03-31 $1,992
2018-12-31 $1,928
2018-09-30 $1,859
2018-06-30 $2,296
2018-03-31 $2,311
2017-12-31 $-4,264
2017-09-30 $2,021
2017-06-30 $2,151
2017-03-31 $2,071
2016-12-31 $1,935
2016-09-30 $2,017
2016-06-30 $1,870
2016-03-31 $1,900
2015-12-31 $1,800
2015-09-30 $1,863
2015-06-30 $1,653
2015-03-31 $1,623
2014-12-31 $1,294
2014-09-30 $1,244
2014-06-30 $1,547
2014-03-31 $1,073
2013-12-31 $1,021
2013-09-30 $1,368
2013-06-30 $1,258
2013-03-31 $1,434
2012-12-31 $788
2012-09-30 $1,107
2012-06-30 $1,266
2012-03-31 $1,184
2011-12-31 $934
2011-09-30 $454
2011-06-30 $1,170
2011-03-31 $1,125
2010-12-31 $1,022
2010-09-30 $1,236
2010-06-30 $1,202
2010-03-31 $1,167
2009-12-31 $931
2009-09-30 $1,386
2009-06-30 $1,269
2009-03-31 $1,019
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $159.699B $33.424B
Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $217.154B 16.21
Gilead Sciences (GILD) United States $138.151B 14.35
Vertex Pharmaceuticals (VRTX) United States $119.760B 0.00
Bristol Myers Squibb (BMY) United States $95.730B 6.41
GSK (GSK) United Kingdom $78.782B 9.43
CSL (CSLLY) Australia $78.007B 0.00
Regeneron Pharmaceuticals (REGN) United States $59.138B 14.35
Alnylam Pharmaceuticals (ALNY) United States $41.398B 0.00
Argenex SE (ARGX) Netherlands $32.889B 89.77
BioNTech SE (BNTX) Germany $26.842B 0.00
Royalty Pharma (RPRX) United States $19.965B 8.43
Biogen (BIIB) United States $19.702B 8.50
Insmed (INSM) United States $18.239B 0.00
Illumina (ILMN) United States $15.714B 29.81
Genmab (GMAB) Denmark $13.633B 15.29
Genmab (GNMSF) Denmark $13.116B 13.41
Incyte (INCY) United States $13.099B 99.51
Moderna (MRNA) United States $12.585B 0.00
Exelixis (EXEL) United States $11.866B 20.14
BioMarin Pharmaceutical (BMRN) United States $11.121B 18.07
QIAGEN (QGEN) Netherlands $10.637B 20.70
Swedish Orphan Biovitrum (BIOVF) Sweden $10.413B 26.59
Ascendis Pharma (ASND) Denmark $10.281B 0.00
Exact Sciences (EXAS) United States $10.100B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $9.549B 0.00
Blueprint Medicines (BPMC) United States $8.292B 0.00
Bio-Techne Corp (TECH) United States $8.259B 30.81
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.395B 0.00
Roivant Sciences (ROIV) United Kingdom $7.383B 0.00
Repligen (RGEN) United States $7.223B 80.86
Legend Biotech (LEGN) United States $6.889B 0.00
Halozyme Therapeutics (HALO) United States $6.876B 13.16
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Revolution Medicines (RVMD) United States $6.788B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.604B 6.48
Anbio Biotechnology (NNNN) Germany $6.511B 0.00
Guardant Health (GH) United States $6.296B 0.00
Nuvalent (NUVL) United States $5.656B 0.00
TG Therapeutics (TGTX) United States $5.653B 148.38
Axsome Therapeutics (AXSM) United States $5.338B 0.00
Telix Pharmaceuticals (TLX) Australia $5.309B 0.00
Alkermes (ALKS) Ireland $4.845B 13.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.734B 0.00
Vaxcyte (PCVX) United States $4.316B 0.00
ADMA Biologics Inc (ADMA) United States $4.252B 31.80
Zealand Pharma (ZLDPF) Denmark $4.230B 0.00
Rhythm Pharmaceuticals (RYTM) United States $4.144B 0.00
Krystal Biotech (KRYS) United States $4.142B 31.92
Cytokinetics (CYTK) United States $4.090B 0.00
Akero Therapeutics (AKRO) United States $4.015B 0.00
Zai Lab (ZLAB) China $3.881B 0.00
PTC Therapeutics (PTCT) United States $3.777B 6.57
Ultragenyx Pharmaceutical (RARE) United States $3.727B 0.00
Arcellx (ACLX) United States $3.668B 0.00
Merus (MRUS) Netherlands $3.622B 0.00
Ascentage Pharma Group - (AAPG) China $3.602B 0.00
Avidity Biosciences (RNA) United States $3.525B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.518B 30.91
Viking Therapeutics (VKTX) United States $3.391B 0.00
Scholar Rock Holding (SRRK) United States $3.251B 0.00
Metsera (MTSR) United States $3.164B 0.00
Protagonist Therapeutics (PTGX) United States $3.081B 66.27
MoonLake Immunotherapeutics (MLTX) Switzerland $2.993B 0.00
Immunovant (IMVT) United States $2.887B 0.00
Kymera Therapeutics (KYMR) United States $2.828B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.777B 0.00
Alvotech (ALVO) Luxembourg $2.656B 15.19
Mirum Pharmaceuticals (MIRM) United States $2.490B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.422B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.411B 0.00
ImmunityBio (IBRX) United States $2.392B 0.00
Apellis Pharmaceuticals (APLS) United States $2.248B 0.00
Ligand Pharmaceuticals (LGND) United States $2.221B 0.00
Twist Bioscience (TWST) United States $2.216B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.179B 0.00
Bavarian Nordic (BVNRY) Denmark $2.128B 11.24
Agios Pharmaceuticals (AGIO) United States $2.101B 0.00
Denali Therapeutics (DNLI) United States $2.082B 0.00
Beam Therapeutics (BEAM) United States $2.041B 0.00
Vericel (VCEL) United States $2.022B 1339.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.986B 0.00
CG Oncology (CGON) United States $1.979B 0.00
NovoCure (NVCR) Jersey $1.952B 0.00
Amicus Therapeutics (FOLD) United States $1.915B 207.33
Belite Bio (BLTE) United States $1.914B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.881B 12.50
IDEAYA Biosciences (IDYA) United States $1.879B 0.00
Sarepta Therapeutics (SRPT) United States $1.870B 0.00
Certara (CERT) United States $1.849B 34.54
Disc Medicine (IRON) United States $1.835B 0.00
Adaptive Biotechnologies (ADPT) United States $1.784B 0.00
Apogee Therapeutics (APGE) United States $1.677B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.672B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.668B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.640B 0.00
GRAIL (GRAL) United States $1.541B 0.00
Vera Therapeutics (VERA) United States $1.467B 0.00
89BIO (ETNB) United States $1.453B 0.00
Janux Therapeutics (JANX) United States $1.447B 0.00
Biohaven (BHVN) United States $1.423B 0.00
Celldex Therapeutics (CLDX) United States $1.416B 0.00
ANI Pharmaceuticals (ANIP) United States $1.410B 14.52
Edgewise Therapeutics (EWTX) United States $1.370B 0.00
Travere Therapeutics (TVTX) United States $1.359B 0.00
Mesoblast (MESO) Australia $1.335B 0.00
Viridian Therapeutics (VRDN) United States $1.310B 0.00
Dynavax Technologies (DVAX) United States $1.272B 75.64
CureVac (CVAC) Germany $1.216B 5.89
AbCellera Biologics (ABCL) Canada $1.161B 0.00
Intellia Therapeutics (NTLA) United States $1.152B 0.00
Novavax (NVAX) United States $1.140B 2.66
Cogent Biosciences (COGT) United States $1.114B 0.00
MannKind (MNKD) United States $1.100B 22.62
Liquidia Technologies (LQDA) United States $1.092B 0.00
WAVE Life Sciences (WVE) Singapore $1.081B 0.00
Structure Therapeutics (GPCR) United States $1.074B 0.00
Pacira BioSciences (PCRX) United States $1.073B 10.21
MiMedx (MDXG) United States $1.034B 25.00
Cidara Therapeutics (CDTX) United States $1.017B 0.00
BGM Group (BGM) China $0.965B 0.00
NeoGenomics (NEO) United States $0.959B 0.00
Praxis Precision Medicines (PRAX) United States $0.952B 0.00
Sionna Therapeutics (SION) United States $0.952B 0.00
Niagen Bioscience (NAGE) United States $0.943B 133.00
Spyre Therapeutics (SYRE) United States $0.941B 0.00
Pharvaris (PHVS) Netherlands $0.940B 0.00
Nurix Therapeutics (NRIX) United States $0.931B 0.00
Mineralys Therapeutics (MLYS) United States $0.909B 0.00
Zymeworks (ZYME) United States $0.902B 0.00
Arcus Biosciences (RCUS) United States $0.900B 0.00
Oric Pharmaceuticals (ORIC) United States $0.889B 0.00
Geron (GERN) United States $0.885B 0.00
LENZ Therapeutics (LENZ) United States $0.883B 0.00
Sana Biotechnology (SANA) United States $0.877B 0.00
Anavex Life Sciences (AVXL) United States $0.870B 0.00
Oculis Holding AG (OCS) Switzerland $0.814B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
UniQure (QURE) Netherlands $0.791B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
CorMedix Inc (CRMD) United States $0.765B 51.27
Gyre Therapeutics (GYRE) United States $0.761B 203.00
Syndax Pharmaceuticals (SNDX) United States $0.753B 0.00
GH Research (GHRS) Ireland $0.753B 0.00
Immunome (IMNM) United States $0.744B 0.00
Vir Biotechnology (VIR) United States $0.733B 0.00
Pharming Group (PHAR) Netherlands $0.720B 0.00
Replimune (REPL) United States $0.720B 0.00
AnaptysBio (ANAB) United States $0.712B 0.00
Nuvation Bio (NUVB) United States $0.698B 0.00
ArriVent BioPharma (AVBP) United States $0.696B 0.00
Trevi Therapeutics (TRVI) United States $0.687B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.685B 0.00
Immatics (IMTX) Germany $0.683B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.670B 0.00
Maze Therapeutics (MAZE) United States $0.660B 0.00
Stoke Therapeutics (STOK) United States $0.656B 15.20
Ginkgo Bioworks Holdings (DNA) United States $0.651B 0.00
MeiraGTx Holdings (MGTX) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Urogen Pharma (URGN) United States $0.632B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.630B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.628B 0.00
Tango Therapeutics (TNGX) United States $0.618B 0.00
Arbutus Biopharma (ABUS) United States $0.609B 0.00
Jyong Biotech (MENS) Taiwan $0.598B 0.00
Iovance Biotherapeutics (IOVA) United States $0.591B 0.00
Dianthus Therapeutics (DNTH) United States $0.587B 0.00
Upstream Bio (UPB) United States $0.586B 0.00
Arvinas (ARVN) United States $0.585B 0.00
Sage Therapeutics (SAGE) United States $0.574B 0.00
Castle Biosciences (CSTL) United States $0.571B 38.74
Keros Therapeutics (KROS) United States $0.565B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.564B 0.00
Prime Medicine (PRME) United States $0.551B 0.00
Tyra Biosciences (TYRA) United States $0.526B 0.00
Opthea (OPT) Australia $0.525B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.519B 0.00
Myriad Genetics (MYGN) United States $0.512B 0.00
Celcuity (CELC) United States $0.507B 0.00
Septerna (SEPN) United States $0.505B 0.00
Bicara Therapeutics (BCAX) United States $0.505B 0.00
Kura Oncology (KURA) United States $0.503B 0.00
Precigen (PGEN) United States $0.502B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.493B 0.00
Abivax SA (ABVX) France $0.492B 0.00
ATyr Pharma (ATYR) United States $0.462B 0.00
Rapport Therapeutics (RAPP) United States $0.461B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.450B 0.00
Kamada (KMDA) Israel $0.443B 26.55
REGENXBIO (RGNX) United States $0.438B 0.00
MBX Biosciences (MBX) United States $0.437B 0.00
Cytek Biosciences (CTKB) United States $0.434B 0.00
PureTech Health (PRTC) United States $0.434B 0.00
Cullinan Therapeutics (CGEM) United States $0.434B 0.00
Fortrea Holdings (FTRE) United States $0.433B 11.98
Rezolute (RZLT) United States $0.425B 0.00
Fulcrum Therapeutics (FULC) United States $0.424B 0.00
Eton Pharmaceuticals (ETON) United States $0.424B 0.00
Zenas BioPharma (ZBIO) United States $0.417B 0.00
Erasca (ERAS) United States $0.414B 0.00
Solid Biosciences (SLDB) United States $0.406B 0.00
Humacyte (HUMA) United States $0.399B 0.00
Terns Pharmaceuticals (TERN) United States $0.396B 0.00
ITeos Therapeutics (ITOS) United States $0.387B 0.00
Tectonic Therapeutic (TECX) United States $0.385B 0.00
Vigil Neuroscience (VIGL) United States $0.382B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.374B 0.00
Emergent Biosolutions (EBS) United States $0.373B 0.00
Compass Therapeutics (CMPX) United States $0.366B 0.00
Astria Therapeutics (ATXS) United States $0.362B 0.00
Northwest Biotherapeutics (NWBO) United States $0.352B 0.00
Prothena (PRTA) Ireland $0.351B 0.00
Amarin (AMRN) Ireland $0.349B 0.00
Absci (ABSI) United States $0.337B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.331B 0.00
Benitec Biopharma (BNTC) United States $0.331B 0.00
Inventiva S.A (IVA) France $0.331B 0.00
Olema Pharmaceuticals (OLMA) United States $0.317B 0.00
XOMA Royalty (XOMA) United States $0.317B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.316B 0.00
Aura Biosciences (AURA) United States $0.314B 0.00
Atea Pharmaceuticals (AVIR) United States $0.313B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.311B 63.25
Ocugen (OCGN) United States $0.307B 0.00
Citius Oncology (CTOR) United States $0.305B 0.00
Lifecore Biomedical (LFCR) United States $0.303B 0.00
Vor Biopharma (VOR) $0.300B 0.00
Abeona Therapeutics (ABEO) United States $0.299B 0.00
Annexon (ANNX) United States $0.297B 0.00
Crescent Biopharma (CBIO) United States $0.295B 0.00
Cartesian Therapeutics (RNAC) United States $0.293B 0.00
DBV Technologies S.A (DBVT) France $0.290B 0.00
Neurogene (NGNE) United States $0.289B 0.00
Gossamer Bio (GOSS) United States $0.289B 0.00
Inhibrx Biosciences (INBX) United States $0.289B 0.17
Vanda Pharmaceuticals (VNDA) United States $0.286B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.285B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.284B 0.00
Aardvark Therapeutics (AARD) United States $0.283B 0.00
Sagimet Biosciences (SGMT) United States $0.281B 0.00
Palvella Therapeutics (PVLA) United States $0.275B 0.00
Foghorn Therapeutics (FHTX) United States $0.273B 0.00
Entrada Therapeutics (TRDA) United States $0.272B 8.84
Corvus Pharmaceuticals (CRVS) United States $0.270B 0.00
Alpha Teknova (TKNO) United States $0.270B 0.00
Candel Therapeutics (CADL) United States $0.263B 0.00
Allogene Therapeutics (ALLO) United States $0.262B 0.00
Cardiff Oncology (CRDF) United States $0.262B 0.00
Verastem (VSTM) United States $0.259B 0.00
Prima BioMed (IMMP) Australia $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.247B 0.00
Adherex Technologies (FENC) United States $0.240B 0.00
Editas Medicine (EDIT) United States $0.239B 0.00
MaxCyte (MXCT) United States $0.236B 0.00
Monopar Therapeutics (MNPR) United States $0.235B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.231B 0.00
Semper Paratus Acquisition (TVGN) United States $0.224B 0.00
Codexis (CDXS) United States $0.221B 0.00
Adocia (ADOCY) France $0.216B 0.00
CARGO Therapeutics (CRGX) United States $0.211B 0.00
ScPharmaceuticals (SCPH) United States $0.209B 0.00
SELLAS Life Sciences (SLS) United States $0.209B 0.00
AC Immune (ACIU) Switzerland $0.208B 0.00
Design Therapeutics (DSGN) United States $0.207B 0.00
Kodiak Sciences (KOD) United States $0.206B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.205B 0.00
Tvardi Therapeutics (TVRD) United States $0.205B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.201B 0.00
BioStem Technologies (BSEM) $0.201B 8.17
EnGene Holdings (ENGN) Canada $0.196B 0.00
CytomX Therapeutics (CTMX) United States $0.193B 5.00
Y-mAbs Therapeutics (YMAB) United States $0.191B 0.00
Alumis (ALMS) United States $0.189B 0.00
Bright Minds Biosciences (DRUG) United States $0.188B 0.00
GENFIT S.A (GNFT) France $0.184B 0.00
I-Mab (IMAB) United States $0.180B 0.00
Puma Biotechnology (PBYI) United States $0.178B 4.66
Voyager Therapeutics (VYGR) United States $0.176B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.174B 0.00
Alpha Cognition (ACOG) Canada $0.171B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.166B 0.00
Spero Therapeutics (SPRO) United States $0.164B 0.00
Innate Pharma S.A (IPHA) France $0.161B 0.00
Nuvectis Pharma (NVCT) United States $0.158B 0.00
Anika Therapeutics (ANIK) United States $0.157B 0.00
BioAge Labs (BIOA) United States $0.157B 0.00
DiaMedica Therapeutics (DMAC) United States $0.157B 0.00
Instil Bio (TIL) United States $0.154B 0.00
Alector (ALEC) United States $0.152B 0.00
Compugen (CGEN) Israel $0.152B 0.00
Caribou Biosciences (CRBU) United States $0.149B 0.00
Ventyx Biosciences (VTYX) United States $0.148B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.147B 0.00
Neumora Therapeutics (NMRA) United States $0.146B 0.00
Molecular Partners AG (MOLN) Switzerland $0.145B 0.00
Theratechnologies (THTX) Canada $0.144B 0.00
Immuneering (IMRX) United States $0.144B 0.00
Black Diamond Therapeutics (BDTX) United States $0.142B 41.67
Greenwich LifeSciences (GLSI) United States $0.135B 0.00
Skye Bioscience (SKYE) United States $0.135B 0.00
Elicio Therapeutics (ELTX) United States $0.135B 0.00
Agenus (AGEN) United States $0.133B 0.00
Rapt Therapeutics (RAPT) United States $0.133B 0.00
Genelux (GNLX) United States $0.131B 0.00
Seer (SEER) United States $0.128B 0.00
23andMe Holding (MEHCQ) United States $0.127B 0.00
Nkarta (NKTX) United States $0.126B 0.00
Fate Therapeutics (FATE) United States $0.125B 0.00
Actuate Therapeutics (ACTU) United States $0.122B 0.00
Kyverna Therapeutics (KYTX) United States $0.122B 0.00
C4 Therapeutics (CCCC) United States $0.121B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.120B 0.00
Sangamo Therapeutics (SGMO) United States $0.119B 0.00
Oncolytics Biotech (ONCY) Canada $0.118B 0.00
BioHarvest Sciences (BHST) Canada $0.117B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.112B 0.00
TuHURA Biosciences (HURA) United States $0.108B 0.00
Tenaya Therapeutics (TNYA) United States $0.103B 0.00
HilleVax (HLVX) United States $0.103B 0.00
Contineum Therapeutics (CTNM) United States $0.101B 0.00
Seres Therapeutics (MCRB) United States $0.101B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Coya Therapeutics (COYA) United States $0.100B 0.00
Nautilus Biotechnology (NAUT) United States $0.100B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.099B 0.00
OKYO Pharma (OKYO) $0.098B 0.00
TScan Therapeutics (TCRX) United States $0.096B 0.00
IO Biotech (IOBT) Denmark $0.096B 0.00
Coherus Oncology (CHRS) United States $0.094B 0.00
Whitehawk Therapeutics (WHWK) United States $0.094B 0.00
Elutia (ELUT) United States $0.093B 0.00
XBiotech (XBIT) United States $0.092B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.091B 0.00
Cellectis S.A (CLLS) France $0.089B 0.00
BeyondSpring (BYSI) United States $0.089B 0.00
Adagene (ADAG) China $0.089B 0.00
Invivyd (IVVD) United States $0.086B 0.00
Climb Bio (CLYM) United States $0.085B 0.00
EXoZymes (EXOZ) United States $0.084B 0.00
Forte Biosciences (FBRX) United States $0.082B 0.00
Zura Bio (ZURA) United States $0.082B 0.00
Entera Bio (ENTX) Israel $0.081B 0.00
ABVC BioPharma (ABVC) United States $0.080B 0.00
IGM Biosciences (IGMS) United States $0.080B 0.00
Immunic (IMUX) United States $0.079B 0.00
TELA Bio (TELA) United States $0.078B 0.00
Cabaletta Bio (CABA) United States $0.077B 0.00
Immix Biopharma (IMMX) United States $0.074B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.073B 0.00
Quince Therapeutics (QNCX) United States $0.073B 0.00
Pliant Therapeutics (PLRX) United States $0.073B 0.00
VistaGen Therapeutics (VTGN) United States $0.072B 0.00
Genenta Science S.p.A (GNTA) Italy $0.070B 0.00
Biomea Fusion (BMEA) United States $0.070B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.068B 0.00
Alto Neuroscience (ANRO) United States $0.068B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.067B 0.00
Sutro Biopharma (STRO) United States $0.066B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
Repare Therapeutics (RPTX) Canada $0.066B 0.00
Clearside Biomedical (CLSD) United States $0.065B 0.00
Akoya Biosciences (AKYA) United States $0.064B 0.00
Oncobiologics (OTLK) United States $0.063B 0.00
Opus Genetics (IRD) United States $0.063B 0.00
Connect Biopharma Holdings (CNTB) United States $0.063B 0.00
MediciNova (MNOV) United States $0.061B 0.00
InflaRx (IFRX) Germany $0.059B 0.00
Adlai Nortye (ANL) Cayman Islands $0.058B 0.00
PDS Biotechnology (PDSB) United States $0.058B 0.00
Senti Biosciences (SNTI) United States $0.057B 0.00
Fortress Biotech (FBIO) United States $0.057B 0.00
Adicet Bio (ACET) United States $0.056B 0.00
Atara Biotherapeutics (ATRA) United States $0.055B 0.00
Cue Biopharma (CUE) United States $0.055B 0.00
CervoMed (CRVO) United States $0.055B 0.00
INmune Bio (INMB) United States $0.054B 0.00
ZIVO Bioscience (ZIVO) United States $0.053B 0.00
Earth Science Tech (ETST) United States $0.053B 0.00
Renovaro (RENB) United States $0.053B 0.00
Applied Therapeutics (APLT) United States $0.052B 0.00
VTv Therapeutics (VTVT) United States $0.051B 0.00
Quantum Biopharma (QNTM) Canada $0.051B 0.00
Aligos Therapeutics (ALGS) United States $0.050B 0.00
Adverum Biotechnologies (ADVM) United States $0.050B 0.00
Precision BioSciences (DTIL) United States $0.050B 0.00
Annovis Bio (ANVS) United States $0.049B 0.00
Inovio Pharmaceuticals (INO) United States $0.049B 0.00
Kalaris Therapeutics (KLRS) United States $0.048B 0.00
Werewolf Therapeutics (HOWL) United States $0.048B 0.00
RenovoRx (RNXT) United States $0.048B 0.00
Jasper Therapeutics (JSPR) United States $0.045B 0.00
Celularity (CELU) United States $0.045B 0.00
Scilex Holding (SCLX) United States $0.044B 0.00
Exicure (XCUR) United States $0.044B 0.00
Pluri (PLUR) Israel $0.044B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
Artiva Biotherapeutics (ARTV) United States $0.041B 0.00
Mersana Therapeutics (MRSN) United States $0.041B 0.00
Medicus Pharma (MDCX) United States $0.041B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Shattuck Labs (STTK) United States $0.039B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
PepGen (PEPG) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
Cognition Therapeutics (CGTX) United States $0.036B 0.00
Alterity Therapeutics - (ATHE) Australia $0.036B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.036B 0.00
Rani Therapeutics Holdings (RANI) United States $0.035B 0.00
Rein Therapeutics (RNTX) United States $0.034B 0.00
Eyenovia (HYPD) United States $0.033B 0.00
KALA BIO (KALA) United States $0.033B 0.00
OnKure Therapeutics (OKUR) United States $0.033B 0.00
Kezar Life Sciences (KZR) United States $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Radiopharm Theranostics - (RADX) Australia $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
Estrella Immunopharma (ESLA) United States $0.032B 0.00
Clene (CLNN) United States $0.031B 0.00
Ovid Therapeutics (OVID) United States $0.031B 0.00
Femasys (FEMY) United States $0.030B 0.00
CAMP4 Therapeutics (CAMP) United States $0.029B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.029B 0.00
Dyadic (DYAI) United States $0.028B 0.00
Passage Bio (PASG) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
Longeveron (LGVN) United States $0.025B 0.00
Boundless Bio (BOLD) United States $0.025B 0.00
ALX Oncology Holdings (ALXO) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Generation Bio (GBIO) United States $0.024B 0.00
FibroBiologics (FBLG) United States $0.023B 0.00
BioAtla (BCAB) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
CalciMedica (CALC) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.022B 0.00
Rallybio (RLYB) United States $0.021B 0.00
Dare Bioscience (DARE) United States $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
BRIACELL THERAP (BCTX) Canada $0.020B 0.00
Curis (CRIS) United States $0.019B 0.00
Cingulate (CING) United States $0.019B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.019B 0.00
Beyond Air (XAIR) United States $0.018B 0.00
Gelteq (GELS) Australia $0.018B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.018B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Q32 Bio (QTTB) United States $0.017B 0.00
Allarity Therapeutics (ALLR) United States $0.016B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
HOOKIPA Pharma (HOOK) United States $0.015B 0.00
Athira Pharma (ATHA) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Advanced Biomed (ADVB) United States $0.014B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.014B 0.00
Synlogic (SYBX) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
Promis Neurosciences (PMN) Canada $0.013B 0.00
Leap Therapeutics (LPTX) United States $0.013B 0.00
Biorestorative Therapies (BRTX) United States $0.013B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.013B 0.00
LakeShore Biopharma (LSB) China $0.013B 0.00
Imunon (IMNN) United States $0.013B 0.00
NextCure (NXTC) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Abpro Holdings (ABP) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
Mustang Bio (MBIO) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.011B 0.00
Synaptogenix (TAOX) United States $0.011B 0.00
Sensei Biotherapeutics (SNSE) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Equillium (EQ) United States $0.011B 0.00
GeoVax Labs (GOVX) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
X4 Pharmaceuticals (XFOR) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Jade Biosciences (JBIO) United States $0.009B 0.00
Artelo Biosciences (ARTL) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.007B 0.00
Intensity Therapeutics (INTS) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
Novogen (KZIA) Australia $0.007B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Mainz Biomed (MYNZ) Germany $0.005B 0.00
Avalon GloboCare (ALBT) United States $0.005B 0.00
180 Life Sciences (ATNF) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
VivoSim Labs (VIVS) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
GRI Bio (GRI) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
UNITY Biotechnology (UBX) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00